Drug intelligence / Profile preview

Bionanomatrix-FD

Development stage
Preclinical
Lead developer
Endomimetics
Modality
Nanoparticles → Drug Delivery Systems, Peptides
Administration
Implantable Device Coating
01

Overview

Bionanomatrix-FD is a peptide-based nanomatrix coating developed by Endomimetics for application on flow diverters used to treat cerebrovascular diseases, specifically intracranial aneurysms. The technology utilizes self-assembling peptide amphiphiles to create a biomimetic environment that provides sustained local delivery of nitric oxide (NO) and incorporates endothelial cell adhesive ligands. This mechanism is designed to accelerate endothelialization over the flow diverter, promote aneurysm occlusion, and reduce complications such as thrombosis, restenosis, and inflammation. By promoting rapid vascular healing, the coating aims to minimize the need for prolonged dual antiplatelet therapy and its associated bleeding risks in brain aneurysm patients.

Brand names
Bionanomatrix
Other names
Bionanomatrix NO-releasing flow diverter coatingBionanomatrix™ (NO-releasing flow diverter coating)
02

Targets

sGC (Soluble Guanylyl Cyclase)

Beyond the preview

Go deeper on Bionanomatrix-FD.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bionanomatrix-FD.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call